About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT03123666

Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis

Informed consent obtained from the patient or the patient's legal surrogate. The window for randomization and initiation of study drug infusion is 2 days from day of Admission. All further time points...

Lead sponsor: Institute of Liver and Biliary Sciences, India•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Institute of Liver and Biliary Sciences, India

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient with cirrhosis admitted to ICU-HDU without pneumonia at admission
•18-70 years of Age
•Child B/ C

Exclusion Criteria

•Patient having pneumonia
•If there is evidence of preexisting chronic respiratory failure
•If the patients is neutropenic (absolute neutrophil count \<1000 cells/mm3
•If there was a history of hematological malignancy or bone marrow transplantation
•Person having HCC
•Acute liver Failure
•Pregnancy
•HIV

Related studies

Microplastics, Cirrhosis and Portal Hypertension

NCT07280390 · Cirrhosis, Microplastics, and more

Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)

NCT06345547 · Sarcopenia, Cirrhosis, and more

RECRUITINGPhase 1

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.

NCT07069725 · Liver Fibrosis, Hepatic Cirrhosis

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

NCT07439939 · Liver Cirrhosis, Portal Hypertension

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 20, 2020Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment160

Start dateApr 2017

Last updatedFeb 20, 2020

Condition

Locations shown

Institute of Liver and Biliary Sciences

New Delhi, National Capital Territory of Delhi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions